Brookstone Capital Management’s iShares iBonds Dec 2031 Term Corporate ETF IBDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-16,955
Closed -$353K – 1343
2026
Q2
$353K Buy
16,955
+221
+1% +$4.61K ﹤0.01% 1040
2026
Q1
$350K Sell
16,734
-1,260
-7% -$26.6K ﹤0.01% 980
2025
Q4
$381K Buy
17,994
+790
+5% +$16.7K ﹤0.01% 921
2025
Q3
$365K Sell
17,204
-803
-4% -$16.9K ﹤0.01% 913
2025
Q2
$379K Sell
18,007
-1,375
-7% -$28.4K 0.01% 828
2025
Q1
$402K Sell
19,382
-7,657
-28% -$157K 0.01% 767
2024
Q4
$550K Buy
27,039
+439
+2% +$9.08K 0.01% 664
2024
Q3
$564K Buy
26,600
+122
+0.5% +$2.54K 0.01% 659
2024
Q2
$545K Buy
26,478
+671
+3% +$13.5K 0.01% 635
2024
Q1
$529K Buy
+25,807
New +$528K 0.01% 616

Other funds holding IBDW

Brookstone Capital Management's IBDW Position: Q3 2026 in Review

Brookstone Capital Management sold out of iShares iBonds Dec 2031 Term Corporate ETF (IBDW) in Q3 2026, closing a stake of 16,955 shares — an estimated $353K sold.

Brookstone Capital Management first reported a position in IBDW in Q1 2024 and held it in 10 quarters. The position peaked at $564K in Q3 2024. 121 funds tracked by Wall St. Rank hold IBDW as of Q3 2026.

  • Brookstone Capital Management reported no remaining iShares iBonds Dec 2031 Term Corporate ETF position as of Q3 2026 after selling out during the quarter.
  • Brookstone Capital Management sold 16,955 iShares iBonds Dec 2031 Term Corporate ETF shares in Q3 2026, an estimated $353K.
  • Brookstone Capital Management first reported a position in iShares iBonds Dec 2031 Term Corporate ETF in Q1 2024 and held it in 10 quarters.
  • Brookstone Capital Management's iShares iBonds Dec 2031 Term Corporate ETF position peaked at $564K in Q3 2024.
  • 121 funds tracked by Wall St. Rank held iShares iBonds Dec 2031 Term Corporate ETF as of Q3 2026.

Based on Brookstone Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.